International Stem Cell (OTCMKTS:ISCO) Stock Crosses Above 200-Day Moving Average – Should You Sell?

by · The Markets Daily

International Stem Cell Corp. (OTCMKTS:ISCO – Get Free Report) crossed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $0.25 and traded as high as $0.29. International Stem Cell shares last traded at $0.2830, with a volume of 26,456 shares changing hands.

International Stem Cell Stock Down 31.3%

The stock has a market cap of $1.46 million, a P/E ratio of -2.23 and a beta of -0.05. The business’s 50-day simple moving average is $0.35 and its two-hundred day simple moving average is $0.25.

International Stem Cell (OTCMKTS:ISCO – Get Free Report) last posted its quarterly earnings results on Thursday, August 13th. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter. The firm had revenue of $2.67 million for the quarter.

About International Stem Cell

(Get Free Report)

International Stem Cell Corporation is a biotechnology company focused on developing therapeutic and commercial applications for human parthenogenetic stem cells. These cells are derived from unfertilized human oocytes and are intended to provide a source of pluripotent stem cells without the use of fertilized embryos.

The company has researched stem-cell-based treatments for conditions including neurological and ophthalmic disorders, while also developing cell-based technologies and related research products.

See Also